ClinicalTrials.Veeva

Menu

Pelvic Inflammatory Disease in COVID-19 Era

U

Università degli Studi di Ferrara

Status

Enrolling

Conditions

Pelvic Inflammatory Disease

Treatments

Other: impact of COVID-19 on Health-Seeking Behaviors

Study type

Observational

Funder types

Other

Identifiers

NCT05648747
826/2022/Oss/AOUFe

Details and patient eligibility

About

The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country.

The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.

Enrollment

300 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Pelvic Inflammatory disease

Exclusion criteria

Pregnancy Oncologic disease

Trial design

300 participants in 2 patient groups

Complicated Pelvic Inflammatory Disease
Description:
The development of complicated Pelvic Inflammatory Disease diagnosed during laparoscopy or by pre-operative image study
Treatment:
Other: impact of COVID-19 on Health-Seeking Behaviors
Non-Complicated Pelvic Inflammatory Disease
Description:
No development of complicated Pelvic Inflammatory Disease diagnosed during laparoscopy or by pre-operative image study
Treatment:
Other: impact of COVID-19 on Health-Seeking Behaviors

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems